Prima Biomed Issues the Following Notice to Stockholders of the Company

Mon, 20 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SYDNEY, AUSTRALIA--(Marketwired - May 16, 2013) - Prima BioMed Ltd (ASX: PRR) (NASDAQ:

Digirad Corporation Rejects Dissident's Call for New Stockholder Meeting as Yet Another Attempt to Seize Control of the Company

Mon, 20 May 2013 12:00:00 AM GMT

POWAY, CA--(Marketwired - May 20, 2013) - Digirad Corporation (NASDAQ: DRAD) (the "Company") today disclosed that the Red Oak Fund, L.P. ("Red Oak") has filed a complaint and motion for expedited proceedings seeking to set aside the results of the Company's recent annual meeting of stockholders...

BioMarin Pharmaceutical Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)

Mon, 20 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN RAFAEL, Calif., May 20, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that on May 15, 2013, the compensation committee of BioMarin's board of directors approved the...

Progenics Pharmaceuticals, Inc. Added to the Biotechnology Index

Mon, 20 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TARRYTOWN, N.Y., May 17, 2013 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced that it has been selected for addition to the NASDAQ Biotechnology Index (Nasdaq:^NBI) effective...

ACADIA Pharmaceuticals, Inc. Added to Biotechnology Index

Mon, 20 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous...

CytRx Corporation Issues Letter to Stockholders Providing Business Update

Mon, 20 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, announced the issuance of its annual Letter to Stockholders from...

Bristol-Myers Squibb Company Announces Intention to Voluntarily Delist Preferred Stock

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced that it has notified the New York Stock Exchange (NYSE) of its intention to voluntarily delist its $2 Convertible Preferred...

Oxygen Biotherapeutics, Inc. Receives Favorable Listing Decision

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), today announced that the NASDAQ Listing Qualifications Panel (the Panel) has granted the Companys request for continued listing...

PURE Bioscience Stock to Begin Trading on the Marketplace

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO, CA--(Marketwired - May 17, 2013) -

Highlighted Links

Galapagos NV Creates New Warrant Plan

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MECHELEN, BELGIUM--(Marketwired - May 17, 2013) - Galapagos NV (EURONEXT BRUSSELS: GLPG)announced todaythat its Board of Directors created 648,490 warrants under a new...

Stemline Therapeutics, Inc. Prices $60 Million Public Offering of Common Stock

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK, May 16, 2013 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing oncology therapeutics that target both cancer stem cells (CSCs) and...

Vertex Pharmaceuticals (MA) Calls for Redemption of $400 Million in Convertible Senior Subordinated Notes Due 2015

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that it has called for redemption of its outstanding $400.0 million in aggregate principal amount of 3.35% Convertible...

TNI BioTech's CEO Issues Letter to Shareholders Discussing Recent Events

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BETHESDA, Md., May 16, 2013 /PRNewswire/ -- TNI BioTech, Inc., (OTC PINK: TNIB), a biotech company combating fatal...

Hyperion Therapeutics Added to

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SOUTH SAN FRANCISCO, Calif., May 16, 2013 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that it has been selected for addition to the NASDAQ Biotechnology Index (Nasdaq:^NBI...

Elan Corporation PLC Announces Publication of Response Document

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE : ELN) (Elan) today announces publication of a response document in respect of the Echo Pharma Acquisition Limited (Royalty Pharma) offer made on May 2, ...

Santarus Inc. Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Secondary Common Stock Offering

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ: SNTS) today announced the completion of a secondary underwritten public offering of 4,887,500 shares of its common stock, including 637,500 shares sold pursuant...

Merck & Co., Inc. Prices $ 6.5 Billion Debt Offering

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck & Co., Inc. priced today a $6.5 billion public offering of senior unsecured notes. The notes include:

$1,000 million of 0.70% notes due May 2016

Bavarian Nordic - Interim Financial Report for the Period 1 January to 31 March 2013

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

KVISTGAARD, Denmark, May 16, 2013 - Bavarian Nordic A/S (OMX: BAVA) todaypublishes its first quarter 2013 results. Revenue for the period was DKK 206million (2012: DKK 168 million) and the result before...

Cyclacel Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BERKELEY HEIGHTS, N.J., May 15, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), today announced that it is offering to sell, subject to market...

VIVUS, Inc. Announces Pricing of Offering of $220 Million of 4.50% Convertible Senior Notes

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MOUNTAIN VIEW, Calif., May 16, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) announced today the pricing of its offering of $220 million aggregate principal amount of 4.50% convertible senior unsecured...

Lundbeck Inc. Increases its Share Capital by 9,772 Shares (0.005% of Outstanding Shares) as a Result of Employee Warrant Exercise

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Copenhagen, 2013-05-16 11:27 CEST (GLOBE NEWSWIRE) -- Lundbeck increases its share capital by 9,772 shares (0.005% of outstanding shares) as a result of employee warrant exercise.

Help employers find...

Cyclacel Pharmaceuticals, Inc. Announces $20 Million Underwritten Offering

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BERKELEY HEIGHTS, N.J., May 16, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), today announced the pricing of the underwritten offering of 6...

Annual General Meeting of Active Biotech AB

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

The Annual General Meeting of Active Biotech was held on May 15, 2013. In accordance with the Board of Directors' proposal, it was resolved that nO dividend would be paid.

Help employers find you...

Oxygen Biotherapeutics, Inc. Receives Favorable Listing Decision

Thu, 16 May 2013 12:00:00 AM GMT

ACADIA Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten...

BioAmber Inc. Announces Closing of Initial Public Offering

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Minneapolis, MN, May 14, 2013 BioAmber Inc. (BioAmber) (NYSE: BIOA.U),announced today the closing of its initial public offering of 8,000,000 units consisting of one shareof common stock and one warrant...

ACADIA Pharmaceuticals, Inc. Prices Public Offering of Common Stock

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock, offered at a price to the public...

Rockwell Medical Technologies Prices $35.0 Million Public Offering of Common Stock

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WIXOM, Mich., May 15, 2013 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with...

VIVUS, Inc. Announces Proposed Offering of Convertible Senior Notes

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MOUNTAIN VIEW, Calif., May 15, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) announced today that it intends to offer, subject to market and other conditions, $200 million aggregate principal amount of...

Discovery Laboratories Announces Completion of $14.25 Million Public Offering

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WARRINGTON, Pa., May 15, 2013 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO) today announced that it has...

Fibrocell Science, Inc. Announces Approval of Common Stock Listing on

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTC:FCSCD) announced today that its common stock has been approved for listing on the NYSE MKT. Trading is expected to commence on the NYSE MKT on Friday...

Sucampo Pharmaceuticals, Inc. to be Added to the Biotechnology Index

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) today announced that NASDAQ OMX Group, Inc. (NASDAQ: NDAQ) will include the company in the NASDAQ Biotechnology Index (NASDAQ...

RegeneRx Biopharmaceuticals, Inc. Issues Letter to Sharholders

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (the Company or RegeneRx) today issued a letter to shareholders describing its future plans and initiatives...

Omeros Corporation Announces Closing of $16.2 Million Registered Direct Offering of Common Stock

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, May 14, 2013 /PRNewswire/ --Omeros Corporation (NASDAQ: OMER) today reported that it closed the registered...

TopoTarget A/S Release: Shareholder Meetings in Copenhagen and Aarhus

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Topotarget sends out invitation for shareholder meetings in Copenhagen (Tuesday, June 11, 2013) and Aarhus (Thursday, June 13, 2013).

Help employers find you! Check out all the

Synergy Pharmaceuticals Added to Biotechnology Index

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK, May 14, 2013 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that it has been selected for...

SIGA Technologies, Inc. Announces Restatement of Certain Historical Financial Results to Reflect Reclassification of Warrants as a Liability

Mon, 13 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK, May 10, 2013 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight pathogens capable of use as bioweapons, announced...

Warner Chilcott, PLC Release: Announcement Under Irish Takeover Rules Relevant Securities in Issue

Mon, 13 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DUBLIN, Ireland, May 13, 2013 (GLOBE NEWSWIRE) -- In accordance with Rule 2.10 of the Irish Takeover Rules, Warner Chilcott plc (Nasdaq:WCRX) (the "Company") confirms that, as of the close of business on May...

Santarus Inc. Announces Launch of a Proposed Secondary Common Stock Offering by a Selling Stockholder

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ: SNTS) today announced a proposed secondary underwritten public offering of shares of its common stock. All shares will be offered by Cosmo Technologies Limited...

Aceto Corporation Board of Directors Declares Quarterly Cash Dividend

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PORT WASHINGTON, N.Y., May 9, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance...

Oxygen Biotherapeutics, Inc. Announces 20:1 Reverse Stock Split Effective After Market Close on May 10th

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), today announced the effectiveness of a 20-to-one reverse stock split of its common stock. The reverse stock split was approved...

Santarus Inc. Announces Pricing of Secondary Common Stock Offering by a Selling Stockholder

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ: SNTS) today announced the pricing of a secondary underwritten public offering of 4,250,000 shares of its common stock at a price to the public of $18.25 per...

Pain Therapeutics Files Form 8-K Regarding Correspondence From Pfizer Inc.

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

AUSTIN, Texas, May 10, 2013 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) announced today that yesterday it received correspondence from Pfizer, Inc. (NYSE:PFE).

Help employers find you...

Karolinska Development AB - Interim Report January - March 2013

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

STOCKHOLM May 10, 2013. Karolinska Development AB (publ) announces publicationof its Interim report January-March, 2013. A conference call will be held todayat 14.00 CET. Participant access numbers: SE...

NeoStem, Inc. Clarification: No New Securities Being Issued

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK, May 9, 2013 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE MKT:NBS), a leader in the emerging cellular therapy industry, is issuing this press release to clarify for shareholders that NeoStem is not engaged...

BioAmber Inc. Announces Pricing of Initial Public Offering

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MINNEAPOLIS, MN, May 9, 2013 /PRNewswire/ - BioAmber Inc. ("BioAmber") (NYSE: BIOAU), announced today the pricing...

NeoStem, Inc. CEO's Letter to Shareholders

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK, May 9, 2013 (GLOBE NEWSWIRE) --

Dear Shareholders,

We at NeoStem, Inc. (NYSE MKT:NBS) believe that cell therapy has the potential to radically change the face of how diseases...

Discovery Laboratories Announces Proposed Public Offering of Common Stock

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WARRINGTON, Pa., May 9, 2013 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO) today...

Omeros Corporation Announces $16.2 Million Registered Direct Offering of Common Stock

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, May 9, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that it has agreed...

BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc. Announce Special Meetings of Stockholders to Consider Proposed Merger

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LINCOLNSHIRE, Ill. & BAUDETTE, Minn.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc. announced today that each company will hold a...

Sonomax Technologies Announces Listing on the CNSX

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MONTREAL--(BUSINESS WIRE)--Sonomax Technologies Inc. (Sonomax or the Company) (TSX Venture: SHH) is pleased to announce that it has been approved for listing on the Canadian National Stock Exchange ( CNSX...

IntelGenx Corp. Security Holders Approved the Amendment of the 2006 Stock Option Plan

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAINT LAURENT, Quebec, May 9, 2013 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx" or the "Company") announced today that at the Company's Annual General Meeting on May...

Receptos Announces Pricing of Initial Public Offering of Common Stock

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO, May 8, 2013 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today announced the...

Isis Pharmaceuticals, Inc. Prices Public Offering of Common Stock

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CARLSBAD, Calif., May 8, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today the pricing...

Immunotech Laboratories Corporate Shareholder Update Summary

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MONROVIA, Calif., May 9, 2013 (GLOBE NEWSWIRE) -- Immunotech Laboratories, Inc. (Pink Sheets:IMMB) Immunotech Laboratories, Inc. today released the following company updates for shareholders and Investors:...

AEterna Zentaris Announces Election of Directors at Its Annual Meeting of Shareholders

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

QUBEC CITY, May 8, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announces the results of the vote on directors...

MethylGene Announces Plan to Reincorporate in the United States as and List on the

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Montreal, Canada, May 9, 2013 MethylGene Inc. (MethylGene)(TSX:MYG) today announced that its Board of Directors (the Board), after careful analysis, consideration and advice from its legal, tax and accounting...

DiaGenic ASA: Increase in Share Capital

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: Reference is made to the stock exchange announcement from DiaGenic ASA (the "Company")(OSE:DIAG) dated 29 April 2013 regarding the result in the subsequent repair...

Idera Pharmaceuticals, Inc. Announces Closing of Common Share Offering

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals (NASDAQ: IDRA) announced today the closing of its previously announced $16.5 million underwritten public offering of (i) 17,500,000 shares of common stock...

Zealand Pharma Announces Amendments to its Articles of Association

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Copenhagen, 2013-05-08 14:30 CEST (GLOBE NEWSWIRE) -- Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL) (Zealand) informs that the companys Articles of Association have been amended.

Help employers...

Notice of Zealand Pharma ???s Interim Report for Q1 2013

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Copenhagen, 2013-05-08 10:21 CEST (GLOBE NEWSWIRE) -- Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL) (Zealand) a Danish biotechnology company dedicated to the discovery and development of novel peptide drugs...

Warner Chilcott, PLC Declares Semi-Annual Cash Dividend of $0.25 Per Share

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DUBLIN, Ireland, May 7, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Board of Directors declared a semi-annual cash dividend in the amount of $0.25 per share, payable June...

Isis Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CARLSBAD, Calif., May 7, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced...

Bayer HealthCare Commences Cash Tender Offer for All Outstanding Shares of Conceptus, Inc.

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LEVERKUSEN, Germany and WAYNE, N.J., May 7, 2013 /PRNewswire/ -- Bayer's planned acquisition of...

Sigma-Aldrich Corporation Declares $0.215 Per Share Quarterly Dividend

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ST. LOUIS, May 7, 2013 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and...

GW Pharmaceuticals Announces the Closing of Its Initial Public Offering on the Nasdaq Global Market

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LONDON, May 8, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or the "Company"), a biopharmaceutical...

INSYS Therapeutics Announces Closing of IPO and Exercise of Underwriters' Over-Allotment Option

Tue, 07 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PHOENIX, AZ--(Marketwired - May 07, 2013) - Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical...

Karolinska Development AB - Interim Report January - March, Invitation to Conference Call Friday, May 10

Tue, 07 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

STOCKHOLM May 7, 2013. Karolinska Development will publish its Interim reportfor January March 2013 on Friday, May 10, 2013. The company will also host aconference call and an on-line presentation on...

Nuvo Research Inc. to Complete Share Consolidation

Tue, 07 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MISSISSAUGA, ON, May 7, 2013 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI) (the "Company" or "Nuvo"), a specialty...

PledPharma Appoints Advisor for the Commercialization of PledOx®

Mon, 06 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Stockholm, 2013-05-06 08:30 CEST (GLOBE NEWSWIRE) -- PledPharma is looking to license PledOx to a major pharmaceutical company with a proven commitment to oncology. The deal structure is expected to include...

Novo Nordisk A/S - Share Repurchase Program

Mon, 06 May 2013 12:00:00 AM GMT

BAGSVAERD, DENMARK--(Marketwired - May 03, 2013) -

Company Announcement No 34 2013:

http://hugin.info/2013/R/1699315/560490.pdf

This announcement is distributed by Thomson Reuters on behalf of ThomsonReuters clients. The owner of this announcement warrants that:

(i) the releases...

Change in the Number of Votes Relating to BioTie Therapies Corp.'s Shares

Mon, 06 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Change in the number of votes relating to Biotie Therapies Corp.'s shares

The Swiss subsidiary of Biotie Therapies Corp. ("Biotie" or the "Company"),Biotie Therapies AG (previously Synosia Therapeutics...

Adamis Pharmaceuticals CEO Provides Update for Shareholders

Mon, 06 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO, May 3, 2013 /PRNewswire/ -- Dennis J. Carlo, Ph.D., the President and Chief Executive Officer of Adamis Pharmaceuticals...

Lignol Provides Addional Funding to Territory Biofuels Limited to Obtain Fully Diluted Majority Interest

Mon, 06 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VANCOUVER, May 6, 2013 /CNW/ - Lignol Energy Corporation (TSXV: LEC) ("LEC" or "the Company"), a leading technology...

BioSpace.com News

NPS Pharmaceuticals, Inc. Announces Proposed Public Offering of 6,000,000 Shares of Its Common Stock

ACADIA Pharmaceuticals, Inc. Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Public Offering of Common Stock

H. Lundbeck A/S ??? Admittance to Trading and Official Listing of New Shares Due to Exercise of Warrants

Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January - March 2013

Royalty Pharma Increases Offer for Elan Corporation PLC to $12.50 Per Share in All Cash

Landauer Declares Regular Cash Dividend

Prima Biomed Issues the Following Notice to Stockholders of the Company

Digirad Corporation Rejects Dissident's Call for New Stockholder Meeting as Yet Another Attempt to Seize Control of the Company

BioMarin Pharmaceutical Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)

Progenics Pharmaceuticals, Inc. Added to the Biotechnology Index

ACADIA Pharmaceuticals, Inc. Added to Biotechnology Index

CytRx Corporation Issues Letter to Stockholders Providing Business Update

Bristol-Myers Squibb Company Announces Intention to Voluntarily Delist Preferred Stock

Oxygen Biotherapeutics, Inc. Receives Favorable Listing Decision

PURE Bioscience Stock to Begin Trading on the Marketplace

Galapagos NV Creates New Warrant Plan

Stemline Therapeutics, Inc. Prices $60 Million Public Offering of Common Stock

Vertex Pharmaceuticals (MA) Calls for Redemption of $400 Million in Convertible Senior Subordinated Notes Due 2015

TNI BioTech's CEO Issues Letter to Shareholders Discussing Recent Events

Hyperion Therapeutics Added to

Elan Corporation PLC Announces Publication of Response Document

Santarus Inc. Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Secondary Common Stock Offering

Merck & Co., Inc. Prices $ 6.5 Billion Debt Offering

Bavarian Nordic - Interim Financial Report for the Period 1 January to 31 March 2013

Cyclacel Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

VIVUS, Inc. Announces Pricing of Offering of $220 Million of 4.50% Convertible Senior Notes

Lundbeck Inc. Increases its Share Capital by 9,772 Shares (0.005% of Outstanding Shares) as a Result of Employee Warrant Exercise

Cyclacel Pharmaceuticals, Inc. Announces $20 Million Underwritten Offering

Annual General Meeting of Active Biotech AB

Oxygen Biotherapeutics, Inc. Receives Favorable Listing Decision

ACADIA Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

BioAmber Inc. Announces Closing of Initial Public Offering

ACADIA Pharmaceuticals, Inc. Prices Public Offering of Common Stock

Rockwell Medical Technologies Prices $35.0 Million Public Offering of Common Stock

VIVUS, Inc. Announces Proposed Offering of Convertible Senior Notes

Discovery Laboratories Announces Completion of $14.25 Million Public Offering

Fibrocell Science, Inc. Announces Approval of Common Stock Listing on

Sucampo Pharmaceuticals, Inc. to be Added to the Biotechnology Index

RegeneRx Biopharmaceuticals, Inc. Issues Letter to Sharholders

Omeros Corporation Announces Closing of $16.2 Million Registered Direct Offering of Common Stock

TopoTarget A/S Release: Shareholder Meetings in Copenhagen and Aarhus

Synergy Pharmaceuticals Added to Biotechnology Index

SIGA Technologies, Inc. Announces Restatement of Certain Historical Financial Results to Reflect Reclassification of Warrants as a Liability

Warner Chilcott, PLC Release: Announcement Under Irish Takeover Rules Relevant Securities in Issue

Santarus Inc. Announces Launch of a Proposed Secondary Common Stock Offering by a Selling Stockholder

Aceto Corporation Board of Directors Declares Quarterly Cash Dividend

Oxygen Biotherapeutics, Inc. Announces 20:1 Reverse Stock Split Effective After Market Close on May 10th

Santarus Inc. Announces Pricing of Secondary Common Stock Offering by a Selling Stockholder

Pain Therapeutics Files Form 8-K Regarding Correspondence From Pfizer Inc.

Karolinska Development AB - Interim Report January - March 2013

NeoStem, Inc. Clarification: No New Securities Being Issued

BioAmber Inc. Announces Pricing of Initial Public Offering

NeoStem, Inc. CEO's Letter to Shareholders

Discovery Laboratories Announces Proposed Public Offering of Common Stock

Omeros Corporation Announces $16.2 Million Registered Direct Offering of Common Stock

BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc. Announce Special Meetings of Stockholders to Consider Proposed Merger

Sonomax Technologies Announces Listing on the CNSX

IntelGenx Corp. Security Holders Approved the Amendment of the 2006 Stock Option Plan

Receptos Announces Pricing of Initial Public Offering of Common Stock

Isis Pharmaceuticals, Inc. Prices Public Offering of Common Stock

Immunotech Laboratories Corporate Shareholder Update Summary

AEterna Zentaris Announces Election of Directors at Its Annual Meeting of Shareholders

MethylGene Announces Plan to Reincorporate in the United States as and List on the

DiaGenic ASA: Increase in Share Capital

Idera Pharmaceuticals, Inc. Announces Closing of Common Share Offering

Zealand Pharma Announces Amendments to its Articles of Association

Notice of Zealand Pharma ???s Interim Report for Q1 2013

Warner Chilcott, PLC Declares Semi-Annual Cash Dividend of $0.25 Per Share

Isis Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

Bayer HealthCare Commences Cash Tender Offer for All Outstanding Shares of Conceptus, Inc.

Sigma-Aldrich Corporation Declares $0.215 Per Share Quarterly Dividend

GW Pharmaceuticals Announces the Closing of Its Initial Public Offering on the Nasdaq Global Market

INSYS Therapeutics Announces Closing of IPO and Exercise of Underwriters' Over-Allotment Option

Karolinska Development AB - Interim Report January - March, Invitation to Conference Call Friday, May 10

Nuvo Research Inc. to Complete Share Consolidation

PledPharma Appoints Advisor for the Commercialization of PledOx®

Novo Nordisk A/S - Share Repurchase Program

Change in the Number of Votes Relating to BioTie Therapies Corp.'s Shares

Adamis Pharmaceuticals CEO Provides Update for Shareholders